Загрузка...

A retrospective study of docetaxel and bevacizumab as a second- or later-line chemotherapy for non-small cell lung cancer

Comparative results of second- or later-line bevacizumab plus docetaxel and docetaxel alone for patients with NSCLC have never been reported. In order to evaluate the combined effect of bevacizumab and docetaxel as second- or later-line chemotherapy for NSCLC, a retrospective study was performed. Be...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Mol Clin Oncol
Главные авторы: Kurishima, Koichi, Watanabe, Hiroko, Ishikawa, Hiroichi, Satoh, Hiroaki, Hizawa, Nobuyuki
Формат: Artigo
Язык:Inglês
Опубликовано: D.A. Spandidos 2017
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5492640/
https://ncbi.nlm.nih.gov/pubmed/28685090
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2017.1282
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!